small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (659)
  • Capabilities (89)
  • Experience (83)
  • Insights & News (4,305)
  • Other Results (103)

Professionals 659 results

Samantha Lerner
Samantha Lerner
Partner
  • Chicago
Email
+1 312-558-6463
vCard

Partner

  • Chicago
Thomas B. Walsh
Thomas B. Walsh
Partner
  • Dallas
Email
+1 214-453-6460
vCard

Partner

  • Dallas
George Lombardi
George Lombardi
Partner
  • Chicago
Email
+1 312-558-5969
vCard

Partner

  • Chicago
View All Professionals

Capabilities 89 results

Practice Area

Commercial Litigation & Disputes

Winston represents clients in virtually every type of dispute that could arise from operating a business. While our primary objective is to protect our clients from the need to engage in litigation and enter the courtroom, we take pride in our heavyweight litigation experience and the knowledge that corporate America has repeatedly retained us not just for “bet-the-company” trials, but for “bet-the-industry” cases as well. Our commercial litigators’ track record of success earned the team a national Tier 1 ranking in Best Law Firms® 2025. Our practice is anchored by seasoned litigators, many of whom have been recognized by in-house counsel and their peers as top practitioners in their fields....Read more

Industry

Energy Industry Litigation & Investigations

With our reputation as a trial lawyers’ firm serving as our foundation, we advocate for a variety of power producers, oil and gas companies, and oilfield services providers in high-stakes litigation throughout U.S. district and appellate courts. We also handle sensitive investigations, contentious regulatory and enforcement issues, and arbitration. Our bench is stacked with innovative legal and commercial problem solvers, many of whom came to Winston from in-house positions, amplifying their appreciation for C-suite complexities. By combining our knowledge of the energy industry with first-rate trial skills, and the experience our practitioners have gained from learning our clients’ businesses, we are positioned to obtain the best result for our clients efficiently—whether in the courtroom or a negotiated solution....Read more

Practice Area

Insurance Litigation

For decades, Winston has represented a broad array of clients in the insurance industry, including some of the world’s largest and best-known insurers. Our prowess in and understanding of the insurance industry encompasses not only its products, practices, and services, but also the increasing challenges posed by a world increasingly characterized by a fast-evolving technological landscape as well as financial, political, and environmental instability. Accordingly, Winston’s lawyers are among the most sought-after in the industry—not only by companies currently facing high-stakes litigations and investigations, but by those looking to take preventive action now in order to mitigate and manage their risk in the future....Read more

Experience 83 results

Experience

|

October 27, 2025

Winston Advised GenNx360 Capital Partners in its sale of Aero 3, Inc.

A Winston team led by Justin Levy and Eric Kaufman represented GenNx360 Capital Partners, a New York-based private equity firm investing in industrial and service companies, in connection with the sale of Aero 3, Inc. to VSE Corporation (NASDAQ: VSEC), a leading provider of aviation aftermarket distribution and repair services.  Headquartered in Manchester, New Hampshire, Aero 3 is a diversified global Maintenance, Repair and Overhaul (MRO) service provider and distributor supporting the commercial wheel and brake aftermarket. This transaction builds on GenNx360’s successful buy-and-build strategy....Read more

Experience

|

September 23, 2025

Denali Capital Acquisition Corp Closes Business Combination with Semnur Pharmaceuticals

Winston & Strawn LLP represented Denali Capital Acquisition Corp. (OTCQB: DNQAF), a special purpose acquisition company, in the closing of its previously announced business combination with Semnur Pharmaceuticals, Inc., a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies and a majority-owned subsidiary of Scilex Holding Company (Nasdaq: SCLX).  ...Read more

Experience

|

September 8, 2025

Winston Wins Ninth Circuit Reversal and Class Certification in Swimmers’ Antitrust Case, Securing a Global-Impact Settlement with World Aquatics

Winston represents a class of professional swimmers alleging World Aquatics (WA) violated antitrust laws by blocking their participation in the competing  International Swimming League. After WA won summary judgment, Winston successfully appealed, arguing the court applied improper antitrust standards and wrongly denied certification of a damages class. In September 2024, the Ninth Circuit reversed both rulings, reviving all claims and issuing a landmark ruling on the possible application of the per se rule or quick look review to sports-associations rules. Am Law awarded Winston “Litigator of the Week” Runner-Up recognition for the win. In November 2024, the Ninth Circuit denied rehearing. In April 2025, the district court certified a damages class....Read more
View All Experience

Insights & News 4,305 results

Webinar

|

December 17, 2025

Privacy Problems Webinar Series

Join the Winston & Strawn Global Privacy and Data Security Practice team for a conversation on emerging privacy trends to have on your radar as we approach the New Year. Topics will include a discussion of strategies companies can take to protect themselves against a wave of burgeoning claims under California’s Shine the Light Law, recent trends in wiretap lawsuits arising from online website monitoring and email tracking practices (hint: looking at you, Florida), and insights on why companies should pay close attention to commercial email subject lines sent to Washington recipients....Read more

Capital Markets & Securities Law Watch

|

December 16, 2025

|

2 Min Read

SEC and SolarWinds Litigation Dismissed Following Joint Stipulation

The U.S. Securities and Exchange Commission (SEC) case against SolarWinds and its Chief Information Security Officer has been dismissed, closing a high-profile cybersecurity enforcement action. This comes as SEC actions against public companies have dropped 30% year-over-year, with the lowest level of enforcement action since 2012—highlighting a notable slowdown in regulatory activity.

Client Alert

|

December 16, 2025

|

4 Min Read

OCC Releases Preliminary Findings from Debanking Investigation

As Winston & Strawn has detailed in earlier articles and alerts, the Trump administration has prioritized addressing “politicized or unlawful debanking” (i.e., when financial institutions close or refuse to open customer accounts based on a customer’s political affiliation, religion, or involvement in legal but politically disfavored industries), using executive orders, agency bulletins, and internal investigative probes to tackle the subject. The administration’s actions are starting to produce measurable results.

View All Insights & News

Other Results 103 results

Law Glossary

What Is Advertising Litigation?

Advertising litigation is defined as the legal area that covers false or deceptive advertising cases. Lawsuits may be brought by government agencies or corporate competitors based on the Lanham Act—a law that specifically deals with false advertising. The Act outlines how an advertisement can be deemed false. The Federal Trade Commission (FTC) has the ability to file lawsuits to halt deceptive advertising claims. The U.S. Food and Drug Administration may also pursue advertising litigation against violators of government regulations. Companies may be called on to substantiate their advertising claims, whether these are made in print or online....Read more

Site Content

Winston Legal Solutions Litigation Legal Services

Law Glossary

What Are the Patent Litigation Differences Between the BPCIA and Hatch-Waxman Act?

There are fundamental differences between the abbreviated approval processes to obtain FDA approval for biosimilars and generic drugs as those processes relate to patent litigation....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising